Oncology & Cancer

Are we overestimating lifetime cancer risks?

The method employed in Australia to calculate the lifetime risks of cancer diagnosis and mortality overestimates these risks, especially for men, according to the authors of research published online today by the Medical ...

Oncology & Cancer

NEJM letter calls prostate cancer screening guidelines into question

Evidence now favors that prostate specific antigen (PSA) testing can help reduce the number of fatal cases of prostate cancer, contrary to earlier recommendations based on a landmark national study. Researchers from NewYork-Presbyterian ...

page 3 from 8